β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases

Clinical and Experimental Metastasis

Volumn 33, Issue 4, 2016, Pages 309-323

  Bleckmann, Annalen ^a   Conradi, Lena Christin ^a   Menck, Kerstin ^a   Schmick, Nadine Annette ^a   Schubert, Antonia ^a   Rietkötter, Eva ^a   Arackal, Jetcy ^a   Middel, Peter ^a   Schambony, Alexandra ^b   Liersch, Torsten ^a   Homayounfar, Kia ^a   Beißbarth, Tim ^a   Klemm, Florian ^a   Binder, Claudia ^a   Pukrop, Tobias ^a,c  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Breast cancer; Metastasis; Prognostic score; WNT signaling

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FRIZZLED PROTEIN; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; WNT PROTEIN; ESTROGEN RECEPTOR ALPHA; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR1 PROTEIN, HUMAN; ROR2 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER METASTASIS; OVERALL SURVIVAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SAMPLE; TUMOR INVASION; WNT SIGNALING PATHWAY; ADULT; AGED; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; SECONDARY; TUMOR CELL LINE;

ADULT; AGED; BETA CATENIN; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; WNT SIGNALING PATHWAY;

EID: 84957678067     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-016-9780-3     Document Type: Article

References (61)

1. De Angelis R et al (2014) Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol 15(1):23–34
2. Cardoso F et al. (2014) ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) dagger. Annals of oncology: Official Journal of the European Society for Medical Oncology/ESMO vol 25(10), pp 1871–88
3. Ruiterkamp J, Ernst MF (2011) The role of surgery in metastatic breast cancer. Eur J Cancer 47(Suppl 3):S6–S22
4. Choti MA (2014) Liver-directed treatments for metastatic colorectal cancer. Curr Treat Options Oncol 15(3):456–464
5. Elsberger B, Roxburgh CS, Horgan PG (2014) Is there a role for surgical resections of hepatic breast cancer metastases? Hepatogastroenterology 61(129):181–186
6. Page AJ et al (2014) Advances in understanding of colorectal liver metastasis and implications for the clinic. Expert Rev Gastroenterol Hepatol 9(2):245–259
7. Krop IE et al (2012) A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine. J Clin Oncol 30(26):3234–3241
8. Emons G, Ghadimi M, Grade M (2015) General principles of tumour biology in visceral surgery. Zentralbl Chir 140(1):74–82
9. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9(4):274–284
10. Vanharanta S, Massague J (2013) Origins of metastatic traits. Cancer Cell 24(4):410–421
11. Nguyen DX, Massague J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8(5):341–352
12. Langley RR, Fidler IJ (2011) The seed and soil hypothesis revisited—the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer (J Int Cancer), vol 128(11), pp 2527–2535
13. Gerlinger M et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892
14. Huang Y et al (2014) Multilayered molecular profiling supported the monoclonal origin of metastatic renal cell carcinoma. Int J Cancer (J Int Cancer), vol 135(1), pp 78–87
15. Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9(4):302–312
16. Stoecklein NH, Klein CA (2010) Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer (J Int Cancer), vol 126(3), pp 589–98
17. Chambers AF, Groom AC, Macdonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2(8):563–572
18. Chuang HN et al (2013) Carcinoma cells misuse the host tissue damage response to invade the brain. Glia 61(8):1331–1346
19. Kienast Y et al (2009) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16(1):116–122
20. Valiente M et al (2014) Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156(5):1002–1016
21. Pukrop T et al (2010) Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 58(12):1477–1489
22. Bleckmann A et al (2013) Nuclear LEF1/TCF4 correlate with poor prognosis but not with nuclear beta-catenin in cerebral metastasis of lung adenocarcinomas. Clin Exp Metastasis 30(4):471–482
23. Klemm F et al (2011) beta-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis 32(3):434–442
24. Clevers H, Loh KM, Nusse R (2014) Stem cell signaling. An integral program for tissue renewal and regeneration: wnt signaling and stem cell control. Science 346(6205):1248012
25. Nusse R (2012) Wnt signaling. Cold Spring Harb Perspect Biol 4(5):a011163
26. Reya T, Clevers H (2005) Wnt signalling in stem cells and cancer. Nature 434(7035):843–850
27. Gessert S, Kuhl M (2010) The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ Res 107(2):186–199
28. Ocana OH et al (2012) Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22(6):709–724
29. Giancotti FG (2013) Mechanisms governing metastatic dormancy and reactivation. Cell 155(4):750–764
30. Li J, Zhou BP (2011) Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 11:49
31. van de Wetering M et al (2001) Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res 61(1):278–284
32. Gilles C et al (2003) Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 63(10):2658–2664
33. Zhang S et al (2012) ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS ONE 7(3):e31127
34. Henry C et al (2015) Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both beta-catenin dependent and independent Wnt signalling. J Cancer Res Clin Oncol 141(2):243–254
35. Kikuchi A et al (2012) Wnt5a: its signalling, functions and implication in diseases. Acta Physiol 204(1):17–33
36. Pukrop T, Binder C (2008) The complex pathways of Wnt 5a in cancer progression. J Mol Med 86(3):259–266
37. Witte F et al (2010) Receptor tyrosine kinase-like orphan receptor 2 (ROR2) and Indian hedgehog regulate digit outgrowth mediated by the phalanx-forming region. Proc Natl Acad Sci USA 107(32):14211–14216
38. Gentzel M et al (2015) Distinct functionality of dishevelled isoforms on Ca2 +/calmodulin-dependent protein kinase 2 (CamKII) in Xenopus gastrulation. Mol Biol Cell 26(5):966–977
39. Hagemann T et al (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25(8):1543–1549
40. van de Vijver M et al (2007) Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study. Breast Cancer Res 9(5):R68
41. McShane LM et al (2006) REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat 100(2):229–235
42. Nishita M et al (2010) Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Mol Cell Biol 30(14):3610–3619
43. Gao S et al (2014) Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling. Cancer Res 74(20):5866–5877
44. Hegazy SA et al (2013) Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma. Cell Signal 25(1):295–307
45. Kwan HT et al (2013) AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/beta-catenin signaling activity. PLoS ONE 8(1):e53597
46. Zhao Y et al (2010) Dishevelled-1 and dishevelled-3 affect cell invasion mainly through canonical and noncanonical Wnt pathway, respectively, and associate with poor prognosis in nonsmall cell lung cancer. Mol Carcinog 49(8):760–770
47. Navarro V et al (2006) Toothbrush-thinking seizures. Epilepsia 47(11):1971–1973
48. Sabol M et al (2014) Surgical management of breast cancer liver metastases. Neoplasma 61(5):601–606
49. Van Cutsem E et al (2014) Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):1–9
50. Bachmeier B et al (2011) Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells. PLoS ONE 6(5):e20550
51. Klemm F, Joyce JA (2014) Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol 25(4):198–213
52. Devaud C et al (2014) Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy. Mol Ther 22(1):18–27
53. Shah SP et al (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461(7265):809–813
54. Ding L et al (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481(7382):506–510
55. Kroigard AB et al (2015) Clonal expansion and linear genome evolution through breast cancer progression from pre-invasive stages to asynchronous metastasis. Oncotarget 6(8):5634–5649
56. Brastianos PK, Cahill DP (2015) Management of brain metastases in the era of targeted and immunomodulatory therapies. Oncology 29(4):261–263
57. Saunus JM et al (2015) Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance. J Pathol 237(3):363–378
58. Luga V et al (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151(7):1542–1556
59. Pukrop T et al (2006) Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci USA 103(14):5454–5459
60. Brastianos PK et al (2015) Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets. Cancer Discov 5(11):1164–1177
61. Paik PK et al (2015) Next-generation sequencing of stage IV squamous cell lung cancers reveals an association of PI3 K aberrations and evidence of clonal heterogeneity in patients with brain metastases. Cancer Discov 5(6):610–621